Natural Product: NPC284651

Natural Product ID:  NPC284651
Common Name:   Uridine-5'-Diphosphoglucuronic Acid
IUPAC Name:   (2S,3S,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Synonyms:   Uridine-5'-Diphosphoglucuronic Acid
Molecular Formula:   C15H22N2O18P2
Standard InCHIKey:  HDYANYHVCAPMJV-LXQIFKJMSA-N
Standard InCHI:  InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1
Canonical SMILES:  O[C@@H]1[C@@H](COP(=O)(OP(=O)(O[C@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(nc1=O)O
First Find Year:  
Max Developmental Stage:  
Synthetic Gene Cluster:   ;

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1797 Homo sapiens Species Hominidae Eukaryota PMID[11420884]
NPO20338 Mus musculus Species Muridae Eukaryota PMID[19425150]
NPO730 Escherichia coli Species Enterobacteriaceae Bacteria PMID[21988831]

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4712 Individual Protein Purinergic receptor P2Y14 Homo sapiens EC50 = 370 nM 17407275
NPT4712 Individual Protein Purinergic receptor P2Y14 Homo sapiens EC50 = 370 nM 19502066

  Similar Natural Products in NPASS

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC284651 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8684 High Similarity NPC149843
0.8684 High Similarity NPC155087
0.7632 Intermediate Similarity NPC283698
0.7632 Intermediate Similarity NPC73765
0.7544 Intermediate Similarity NPC17892
0.7544 Intermediate Similarity NPC36985
0.7438 Intermediate Similarity NPC329277
0.7368 Intermediate Similarity NPC322594
0.7368 Intermediate Similarity NPC320249
0.7353 Intermediate Similarity NPC318142
0.7281 Intermediate Similarity NPC324390
0.7197 Intermediate Similarity NPC325750
0.7034 Intermediate Similarity NPC317639
0.693 Remote Similarity NPC43246
0.693 Remote Similarity NPC89051
0.6807 Remote Similarity NPC324516
0.6807 Remote Similarity NPC318166
0.6797 Remote Similarity NPC316244
0.6667 Remote Similarity NPC106780
0.6639 Remote Similarity NPC327344
0.6504 Remote Similarity NPC328779
0.6475 Remote Similarity NPC315058
0.6471 Remote Similarity NPC171116
0.6471 Remote Similarity NPC315063
0.6423 Remote Similarity NPC90240
0.6423 Remote Similarity NPC120887
0.64 Remote Similarity NPC328914
0.6341 Remote Similarity NPC6166
0.6341 Remote Similarity NPC226769
0.6341 Remote Similarity NPC280946
0.6338 Remote Similarity NPC313962
0.6303 Remote Similarity NPC210456
0.6303 Remote Similarity NPC163352
0.626 Remote Similarity NPC329384
0.6134 Remote Similarity NPC325723
0.605 Remote Similarity NPC112842
0.605 Remote Similarity NPC71339
0.5862 Remote Similarity NPC329077
0.5827 Remote Similarity NPC313813
0.5772 Remote Similarity NPC190334
0.5772 Remote Similarity NPC62927
0.5682 Remote Similarity NPC188453
0.5682 Remote Similarity NPC42320
0.568 Remote Similarity NPC292345

  Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC284651 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7632 Intermediate Similarity NPD9639 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD3129 Phase 3
0.7355 Intermediate Similarity NPD3128 Phase 3
0.7009 Intermediate Similarity NPD1686 Approved
0.6947 Remote Similarity NPD7756 Clinical (unspecified phase)
0.693 Remote Similarity NPD9580 Clinical (unspecified phase)
0.693 Remote Similarity NPD9581 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3139 Phase 3
0.6846 Remote Similarity NPD3138 Phase 3
0.6724 Remote Similarity NPD241 Discontinued
0.6721 Remote Similarity NPD5789 Clinical (unspecified phase)
0.6552 Remote Similarity NPD9557 Clinical (unspecified phase)
0.6439 Remote Similarity NPD7914 Suspended
0.64 Remote Similarity NPD1454 Phase 3
0.64 Remote Similarity NPD1455 Phase 3
0.6393 Remote Similarity NPD1446 Phase 3
0.6393 Remote Similarity NPD1447 Phase 3
0.6357 Remote Similarity NPD1385 Discontinued
0.6299 Remote Similarity NPD7651 Approved
0.6281 Remote Similarity NPD9565 Discontinued
0.6279 Remote Similarity NPD6946 Approved
0.625 Remote Similarity NPD7139 Approved
0.625 Remote Similarity NPD7140 Approved
0.625 Remote Similarity NPD7141 Clinical (unspecified phase)
0.6207 Remote Similarity NPD9556 Approved
0.6198 Remote Similarity NPD755 Phase 3
0.6154 Remote Similarity NPD9561 Approved
0.6154 Remote Similarity NPD9560 Approved
0.6142 Remote Similarity NPD2255 Approved
0.6133 Remote Similarity NPD7761 Suspended
0.6111 Remote Similarity NPD502 Approved
0.6102 Remote Similarity NPD9546 Phase 2
0.6068 Remote Similarity NPD9558 Phase 3
0.605 Remote Similarity NPD280 Approved
0.605 Remote Similarity NPD9533 Phase 2
0.6033 Remote Similarity NPD1760 Approved
0.6014 Remote Similarity NPD6935 Phase 3
0.6014 Remote Similarity NPD6936 Clinical (unspecified phase)
0.595 Remote Similarity NPD240 Phase 3
0.595 Remote Similarity NPD9562 Discovery
0.595 Remote Similarity NPD170 Approved
0.5935 Remote Similarity NPD841 Approved
0.5878 Remote Similarity NPD1061 Clinical (unspecified phase)
0.5873 Remote Similarity NPD501 Phase 1
0.584 Remote Similarity NPD6943 Clinical (unspecified phase)
0.5833 Remote Similarity NPD9529 Phase 1
0.5833 Remote Similarity NPD9559 Phase 1
0.5809 Remote Similarity NPD1805 Phase 2
0.5809 Remote Similarity NPD1804 Phase 2
0.5785 Remote Similarity NPD239 Phase 2
0.5785 Remote Similarity NPD238 Clinical (unspecified phase)
0.5781 Remote Similarity NPD762 Discontinued
0.5772 Remote Similarity NPD9603 Phase 3
0.5772 Remote Similarity NPD9602 Phase 3
0.5772 Remote Similarity NPD9604 Approved
0.5746 Remote Similarity NPD1428 Phase 2
0.5735 Remote Similarity NPD6941 Approved
0.5714 Remote Similarity NPD251 Approved
0.5714 Remote Similarity NPD2633 Phase 1
0.5714 Remote Similarity NPD1407 Approved
0.5714 Remote Similarity NPD4743 Phase 2
0.5692 Remote Similarity NPD881 Approved
0.568 Remote Similarity NPD618 Clinical (unspecified phase)
0.5674 Remote Similarity NPD7992 Clinical (unspecified phase)
0.5662 Remote Similarity NPD6693 Phase 3
0.5634 Remote Similarity NPD6918 Phase 1

Structure

External Identifiers

PubChem CID   17473
ChEMBL   CHEMBL228057
ZINC  

Physicochemical Properties

Molecular Weight:  580.03
ALogP:  -4.5643
MLogP:  0.69
XLogP:  -5.62
# Rotatable Bonds:  18
Polar Surface Area:  331.72
# H-Bond Aceptor:  20
# H-Bond Donor:  9
# Rings:  3
# Heavy Atoms:  37

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs